期刊文献+

预测大肝癌患者预后的列线图:一项基于SEER数据库的研究 被引量:7

A nomogram to predict prognosis of patients with large hepatocellular carcinoma:a study based on SEER database
原文传递
导出
摘要 目的探讨大肝癌患者癌症特异生存的影响因素,并绘制列线图以预测患者的癌症特异生存率。方法检索SEER数据库中1975–2017年期间的大肝癌患者的临床病理数据,按1∶1随机分成训练组和验证组。采用训练组数据,以Cox比例风险回归模型探索癌症特异生存的影响因素并构建列线图;最后绘制受试者工作特征曲线(ROC曲线)和校准曲线对列线图进行内部验证和外部验证。结果多因素Cox比例风险回归模型结果显示,肝硬化程度、肿瘤分化程度、肿瘤直径、T分期、M分期、手术情况和化疗情况是影响大肝癌患者特异生存的独立影响因素(P<0.05),这些因素均纳入列线图用于预测癌症特异生存率。训练组的1、3和5年曲线下面积分别为0.800、0.827和0.814;验证组的1、3和5年曲线下面积分别为0.800、0.824和0.801;训练组的C指数为0.779,验证组为0.777。训练组与验证组的校正曲线接近理想的实际情况曲线。结论本研究绘制的预测模型列线图,在临床可用于预测大肝癌患者的特异生存。 Objective To explore the influencing factors of cancer-specific survival of patients with large hepatocellular carcinoma,and draw a nomogram to predict the cancer-specific survival rate of large hepatocellular carcinoma patients.Methods The clinicopathological data of patients with large hepatocellular carcinoma during the period from 1975 to 2017 in the Surveillance,Epidemiology,and End Results(SEER)database were searched and randomly divided into training group and validation group at 1∶1.Using the training data,the Cox proportional hazard regression model was used to explore the influencing factors of cancer-specific survival and construct the nomogram;finally,the receiver operating characteristic curve(ROC curve)and the calibration curve were drawn to verify the nomogram internally and externally.Results The results of the multivariate Cox proportional hazard regression model showed that the degree of liver cirrhosis,tumor differentiation,tumor diameter,T stage,M stage,surgery,and chemotherapy were independent influencing factors that affect the specific survival of patients with large hepatocellular carcinoma(P<0.05),and then these factors were enrolled into the nomogram of the prediction model.The areas under the1,3,and 5-year curves of the training group were 0.800,0.827,and 0.814,respectively;the areas under the 1,3,and 5-year curves of the validation group were 0.800,0.824,and 0.801,respectively.The C index of the training group was 0.779,and the verification group was 0.777.The calibration curve of the training group and the verification group was close to the ideal curve of the actual situation.Conclusion The nomogram of the prediction model drawn in this study can be used to predict the specific survival of patients with large hepatocellular carcinoma in the clinic.
作者 王维 金宗睿 吴国林 王珏 易麒麟 王继龙 徐邦浩 朱海 彭涛 郭雅 文张 WANG Wei;JIN Zongrui;WU Guolin;WANG Jue;YI Qilin;WANG Jilong;XU Banghao;ZHU Hai;PENG Tao;GUO Ya;WEN Zhang(Department of Hepatobiliary Surgery,The First Affiliated Hospital of Guangxi Medical University,Nanning 530021,P.R.China;The First Clinical Medical College of Guangxi Medical University,Nanning 530021,P.R.China)
出处 《中国普外基础与临床杂志》 CAS 2021年第8期1016-1024,共9页 Chinese Journal of Bases and Clinics In General Surgery
基金 国家自然科学基金地区科学基金项目(项目编号:81560387) 国家自然科学基金青年科学基金项目(项目编号:81902983) 广西自然科学基金青年科学基金项目(项目编号:2018GXNSFBA050030、2018JJB140382) 广西医疗卫生适宜技术开发与推广应用项目(项目编号:S2019097、S2018100)。
关键词 大肝癌 SEER数据库 癌症特异性生存 列线图 预后预测 large hepatocellular carcinoma The Surveillance,Epidemiology,and End Results Database cancer specific survival nomogram prognosis prediction
  • 相关文献

参考文献10

二级参考文献91

  • 1王鲁,汤钊猷.肝癌转移复发模型的建立及其在实验性干预中的应用[J].癌症进展,2005,3(1):17-20. 被引量:8
  • 2Wei Wu, Deng-Fu Yao, Yong-Mei Yuan, Ji-Wei Fan, Xiu-Feng Lu, Xiao-Hua Li, Li-Wei Qiu, Lei Zong and Xin-Hua Wu Research Center of Clinical Molecular Biology, Affiliated Hospital of Nantong University, Nantong 226001, China.Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2006,5(4):538-544. 被引量:26
  • 3Nouso K, Kobayashi Y, Nakamura S, et al. Evolution of prognostic factors in hepatoceUular carcinoma in Japan [ J ]. Aliment Pharmacol Ther. 2010. 31 (3) : 407 - 414.
  • 4Shimada K, Sakamoto Y, Esaki M, et al. Analysis of prognostic factors affecting survival after initial recurrence and treatment efficacy for recurrence in patients undergoing potentially curative hepatectomy for hepatocellular carcinoma [ J ]. Ann Surg 0ncol,2007,14 (8) :2337 - 2347.
  • 5Ko S, Nakajima Y, Kanehiro H, et al. Significant influence of accompanying chronic hepatitis status on recurrence of hepatoceUular carcinoma after hepatectomy. Result of multivariate analysis [ J ]. Ann Surg, 1996,224 (5) :591 -595.
  • 6Vauthey JN, Lauwers GY. Prognostic factors after resection of hepatocellular carcinoma : are there landmarks in the wild forest [J]. J Hepatol,2003,38 (2) :237-239.
  • 7Tandon P, Garcia-Tsao G. Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies [J]. Liver Int,2009,29(4) :502 -510.
  • 8Imamura H, Matsuyama Y, Tanaka E, et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy [J]. J Hepatol,2003,38(2):200-207.
  • 9Greene FL, Page DL,Fleming ID, et al. American JointCommittee on cancer staging manual [ M ]. 6th ed, New York, NY: Springer, 2002:131 - 144.
  • 10Little SA, Fong Y. HepatoceUular carcinoma: current surgical management [ J ]. Semin Oncol, 2001,28 ( 5 ) : 474 - 486.

共引文献1107

同被引文献36

引证文献7

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部